“Kovaxin has not yet been tested in Phase 3. Approval can be premature and dangerous. Please clarify @ drharshvardhan. Use should be avoided until complete testing is complete. India Can start the AstraZeneca vaccine in the meantime, “Tharoor tweeted.
India’s Drug Controller General (DCGI) has approved the Oxford COVID-19 Vaccine Covishield manufactured by the Serum Institute, and has independently developed Barrat Biotech’s Covacin to limit emergency use in the country on a large scale. Paved the way to the inoculation drive.
Approval was granted based on recommendations from the COVID-19 Subject Expert Committee (SEC) of the Central Pharmaceutical Standards Control Organization (CDSCO).
State Health Minister KK Shailaja said the state was ready to distribute the vaccine once the center nodded.
“We will use the vaccine according to the instructions of the central government. With the permission of the center, we are ready to distribute the vaccine. The ice-lined refrigerator (ILR), cold box, etc. are ready, and the state has confirmed the location. To distribute the vaccine, “she told the media.
When asked about the criticisms of Kovacin and Taruru, the minister said the state government had not yet received official notice of the vaccine and would comment on it later.
“We have not yet officially received notifications about the two approved vaccines. We cannot comment without receiving the official details,” said Shailaja.
DCGI recommends that the panel Serum Institute of IndiaOxford-AstraZeneca Vaccine Emergency Use Authorization Application.
The Government of Kerala uses the COVID-19 vaccine as directed by the Center: Minister of Health
https://economictimes.indiatimes.com/news/politics-and-nation/kerala-government-will-use-covid-19-vaccine-as-instructed-by-centre-health-minister/articleshow/80082698.cms The Government of Kerala uses the COVID-19 vaccine as directed by the Center: Minister of Health